272 results on '"Chupp, Geoffrey L."'
Search Results
2. Activated sputum eosinophils associated with exacerbations in children on mepolizumab
3. Correction: iDESC: identifying differential expression in single-cell RNA sequencing data with multiple subjects
4. iDESC: identifying differential expression in single-cell RNA sequencing data with multiple subjects
5. Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19
6. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
7. EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR.
8. Mapping geographic variability of severe uncontrolled asthma in the United States: Management implications
9. The new era of add-on asthma treatments: where do we stand?
10. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
11. Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma.
12. Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
13. Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma
14. Sputum alarmins delineate distinct T2 cytokine pathways and unique subtypes of patients with asthma
15. LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX
16. EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH COMORBID GASTROESOPHAGEAL REFLUX DISEASE: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES
17. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
18. Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study
19. Approaches for integrating heterogeneous RNA-seq data reveal cross-talk between microbes and genes in asthmatic patients
20. Dupilumab Improves Long‐term Outcomes in Patients With Uncontrolled, Moderate‐to‐Severe GINA‐Based Type 2 Asthma, Irrespective of Allergic Status
21. A Chemoattractant Cytokine Associated with Granulomas in Tuberculosis and Silicosis
22. Pulmonary artery pseudoaneurysm causing massive hemoptysis in hyperimmunoglobulin E syndrome: a case report
23. Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40
24. CAPTAIN: EFFECTS OF AGE AS A CONTINUOUS VARIABLE ON ASTHMA CONTROL
25. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
26. A dual role for CRTH2 in acute lung injury
27. Additional file 2 of The new era of add-on asthma treatments: where do we stand?
28. Targeting ST2L Potentiates CpG-Mediated Therapeutic Effects in a Chronic Fungal Asthma Model
29. Inhibition of ABCC1 Decreases cAMP Egress and Promotes Human Airway Smooth Muscle Cell Relaxation
30. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
31. Noninvasive Analysis of the Sputum Transcriptome Discriminates Clinical Phenotypes of Asthma
32. Chitinase 3-like-1 Regulates Both Visceral Fat Accumulation and Asthma-like Th2 Inflammation
33. Myositis Due to Pleistophora (Microsporidia) in a Patient with AIDS
34. Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma
35. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
36. Additional file 2 of Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma
37. Additional file 1 of Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
38. IL-6 Receptor α Defines Effector Memory CD8+ T Cells Producing Th2 Cytokines and Expanding in Asthma
39. Role of Growth Arrest-Specific Gene 6 in the Development of Fungal Allergic Airway Disease in Mice
40. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function
41. Additional file 1 of Approaches for integrating heterogeneous RNA-seq data reveal cross-talk between microbes and genes in asthmatic patients
42. A chitinase-like protein in the lung and circulation of patients with severe asthma
43. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death
44. Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.
45. Role of Breast Regression Protein-39 in the Pathogenesis of Cigarette Smoke-Induced Inflammation and Emphysema
46. Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis
47. Restoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society–coordinated Task Force
48. Single-cell Profiling of the Response to Poly I:C in Peripheral Blood Mononuclear Cells in Severe Asthma
49. Profiling cellular heterogeneity in asthma with single cell multiparameter CyTOF
50. A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.